Found 16 matching trials
Real World Pharmacokinetics of Immune Checkpoint Inhibitors NA Rationale: Real-world pharmacokinetic data from cancer patients treated wit...
Show More Learn More & Join Trial
Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy PHASE3 This phase III trial compares survival in urothelial cancer patients who st...
Show More Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Learn More & Join Trial
Study for Evaluating the Safety and Feasibility of Fecal Microbiota Transplant in Stage II-III NSCLC Patients Using ICI Responders as Donors (MIGRANT) PHASE2 This is a randomized, phase II, multi-centre clinical trial.
Sample size: ...
Show More Location
Hospital General Universitario de Alicante
Learn More & Join Trial
A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON) PHASE2 This is a Phase 2, signal generating, open-label, 2-Arm, non-randomized stu...
Show More Location
Southern Medical Day Care Centre
Learn More & Join Trial
PET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate Risk PHASE2 This phase 2 trial aims to test the feasibility and efficiency of PET/CT-di...
Show More Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
Learn More & Join Trial
Ivarmacitinib in Advanced Solid Tumors: A Prospective, Two-Cohort, Two-Phase Exploratory Study in Patients Discontinued Due to Immune Intolerance PHASE2 This study is a Phase II, two-cohort, multicenter, two-stage clinical trial...
Show More Location
Multiple Locations
Learn More & Join Trial
A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors PHASE1 This is an open-label, non-randomized, Phase 1b/2 study to determine the sa...
Show More Location
Arizona Oncology Associates
Learn More & Join Trial
Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients PHASE2 Non-comparative multicentric randomized study to assess long-term benefit o...
Show More Location
Centre Hospitalier de la Côte Basque
Learn More & Join Trial
A Study to Test the Benefit of Vitamin B5 in Patients With Melanoma PHASE1 This study is open to patients with a type of cancer called melanoma. Patie...
Show More Status
Active Not Recruiting
Location
University Health Network- Princess Margaret Cancer Centre
Learn More & Join Trial
TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer PHASE2 This phase II trial studies how well FASN inhibitor TVB-2640, paclitaxel, a...
Show More Location
Mayo Clinic in Arizona
Learn More & Join Trial